未找到相关数据
Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Of a First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin's Lyphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
被引：17
作者：
Kuruvilla, John
Gutierrez, Martin
Shah, Bijal D.
Gabrail, Nashat Y.
Brown, Peter de Nully
Stone, Richard M.
Garzon, Ramiro
Savona, Michael
Siegel, David S.
Baz, Rachid
Mau-Sorensen, Morten
Davids, Matthew S.
Byrd, John C.
Shacham, Sharon
Rashal, Tami
Yau, Cindy Y. F.
McCauley, Dilara
Saint-Martin, Jean-Richard
McCartney, John
Landesman, Yosef
Klebanov, Boris
Pond, Greg
Oza, Amit M.
Kauffman, Michael
Mirza, Mansoor R.
机构：
来源：
关键词：
D O I：
10.1182/blood.V122.21.90.90
中图分类号：
R5 [内科学];
学科分类号：
1002 ;
100201 ;
摘要：
90
引用
收藏
页数：2
相关论文